Pharmaceutical company to pay $96 million to settle claims of promoting unapproved use of drug for dementia...
By
Lois A. Bowers
Sep 27, 2019
Pharmaceutical company Avanir has agreed to pay $96 million to resolve federal False Claims Act allegations that it paid kickbacks and marketed the drug Nuedexta in long-term care communities for the off-label...
Alzheimer’s cure would result in assisted living losses of $16 billion in annual revenues, 110,000...
By
Lois A. Bowers
Sep 17, 2019
A “novel, simple and fast-acting” cure for Alzheimer’s disease would be a “medical miracle” but would result in a loss of $16.3 billion in annual revenues for the assisted living industry, according...
Home gaining on LTC as final residence for those with Alzheimer’s
By
Lois A. Bowers
May 25, 2017
The majority of people with Alzheimer’s disease die in long-term care facilities, although the percentage is decreasing, whereas the number of people with the disease who die at home is increasing,...
A big lump of coal … and an opportunity
By
Lois A. Bowers
Dec 18, 2023
Christmas came early for the senior living field on Sunday, when providers collectively found a big lump of coal in the industry stocking. But that stocking also contains an opportunity.
Alzheimer’s costs expected to increase by $20 billion this year
By
Lois A. Bowers
Mar 21, 2018
The national cost of caring for those with Alzheimer’s and other dementias is projected to increase $20 billion this year compared with last year, totaling more than $277 billion in 2018, according...
Should residents’ access to Alzheimer’s drug be restricted?
By
Lois A. Bowers
Jan 18, 2022
You have until Feb. 10 to share your comments with CMS about its recent proposal related to Alzheimer’s drug aducanumab (Aduhelm).
NIH asks for $414.4 million more for Alzheimer’s research
By
Lois A. Bowers
Aug 01, 2016
The National Institutes of Health will need $414.4 million more than its base appropriation for Alzheimer’s disease and related dementias in fiscal year 2018 if it is to meet the research goals of...
Public policy issues on agenda for Argentum ‘fly-in’
By
Lois A. Bowers
Sep 19, 2016
Approximately 100 senior living CEOs, senior vice presidents, executive directors and other leaders, as well as Argentum staff members, are descending on the nation’s capital Tuesday and Wednesday...
Largest senior living providers in 2017 named by Argentum
By
Lois A. Bowers
Nov 15, 2017
This year’s list features 115 companies with a total of almost 550,000 independent living, assisted living and memory care units.
Study: Pharmacists help reduce hospital admissions among those with dementia
By
Lois A. Bowers
Apr 05, 2016
If you’re seeking to reduce hospital admissions among those with dementia, involving a clinical pharmacist may help, according to new research from Sweden.